HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 283 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,878 | +12.2% | 2,497 | -0.3% | 0.01% | +14.3% |
| Q2 2023 | $257,536 | -6.7% | 2,504 | -1.0% | 0.01% | -12.5% |
| Q1 2023 | $276,015 | -6.5% | 2,529 | -2.5% | 0.01% | -11.1% |
| Q4 2022 | $295,083 | +100.7% | 2,593 | +9.5% | 0.01% | +80.0% |
| Q3 2022 | $147,000 | -4.5% | 2,369 | +22.8% | 0.01% | 0.0% |
| Q2 2022 | $154,000 | -63.6% | 1,929 | -52.0% | 0.01% | -61.5% |
| Q1 2022 | $423,000 | +193.8% | 4,018 | +201.4% | 0.01% | +225.0% |
| Q4 2021 | $144,000 | +1.4% | 1,333 | +2.5% | 0.00% | -20.0% |
| Q3 2021 | $142,000 | +32.7% | 1,300 | +13.3% | 0.01% | +25.0% |
| Q2 2021 | $107,000 | +10.3% | 1,147 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $97,000 | +47.0% | 1,051 | +17.2% | 0.00% | +33.3% |
| Q4 2020 | $66,000 | -5.7% | 897 | +0.1% | 0.00% | -25.0% |
| Q3 2020 | $70,000 | +125.8% | 896 | +62.3% | 0.00% | +100.0% |
| Q2 2020 | $31,000 | +158.3% | 552 | +31.7% | 0.00% | +100.0% |
| Q1 2020 | $12,000 | +500.0% | 419 | +810.9% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 46 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |